<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02310360</url>
  </required_header>
  <id_info>
    <org_study_id>S56186</org_study_id>
    <nct_id>NCT02310360</nct_id>
  </id_info>
  <brief_title>Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans</brief_title>
  <acronym>DA-Fallypride</acronym>
  <official_title>Measuring Food-induced Striatal and Extra-striatal Dopamine Release Using (18F)Fallypride Positron Emission Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether a combination of taste probes and
      food-related cues can induce dopamine release in striatal and extra-striatal brain regions in
      healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DA release in both striatal and extra-striatal brain regions</measure>
    <time_frame>1 year</time_frame>
    <description>A [18F]Fallypride PET protocol and the linearized simplified reference region model (LSSRM) kinetic model will be used to detect DA release.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Appetite Regulation</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Fallypride</intervention_name>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy females.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  20 ≤ BMI ≤ 25

          -  Right handed

          -  Stable body weight for at least 3 consecutive months at start of study and no history
             of behavioral, therapeutic or surgical treatment aiming at or leading to weight
             loss/gain

          -  Subject understands the study procedures and agrees to participate in the study by
             giving written informed consent

        Exclusion Criteria:

          -  Medical (current or history):

               -  Abdominal/thoracic surgery except appendectomy

               -  Gastrointestinal, endocrine (especially diabetes), or neurological diseases

               -  Cardiovascular, respiratory, renal or urinary diseases

               -  Hypertension

               -  Food or drug allergies

               -  Head trauma with loss of consciousness

          -  Psychiatric disorders (current or history):

               -  Eating disorders

               -  Psychotic disorders

               -  Major depressive disorder

               -  Somatoform disorder

               -  Emotional and/or restraint eating

               -  Treatment in the last 6 months with antidepressants (as MAO inhibitors),
                  neuroleptics, sedative hypnotics, psychostimulants, glucocorticoids, appetite
                  suppressants, estrogens, opiate, or dopamine medications. Oral contraception is
                  allowed

          -  History of cannabis use or any other drug of abuse for at least 12 months prior to the
             study

          -  Intolerance of lactose

          -  Vegetarians

          -  Smoking and alcohol intake greater than 5 alcoholic units per week (one alcoholic unit
             = 10 gr ethanol)

          -  More than moderate exercise (&gt; 30 min, five times per week of walking or equivalent)

          -  High caffeine intake (&gt; 500 ml coffee daily or equivalent)

          -  Exposure to a significant amount (&gt; 1mSv) of ionizing radiation in other research
             studies within the last 12 months

          -  Claustrophobia or too much uneasiness in limited spaces (in order tolerate confinement
             during PET scanning procedures)

          -  Inability or unwillingness to perform all of the study procedures, or if the subject
             is considered unsuitable in any way by the principal investigator

          -  Recent participation (&lt; 30 days) or simultaneous participation in another clinical
             trial

          -  Any condition that would interfere with Magnetic Resonance Imaging (MRI) or PET
             studies (e.g., cochlear implant, metal fragments in eyes, cardiac pacemaker, neural
             stimulator, and metallic body inclusion or other metal implanted in the body which may
             interfere with MRI scanning)

          -  Anemia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukas Van Oudenhove, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Leuven, campus Gasthuisberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Leuven, campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>December 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

